The artificial kidney market is experiencing a transformative surge, driven by the escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide. Valued at US$ 1.5 billion in 2023, the market is projected to expand at a robust compound annual growth rate (CAGR) of 13%, reaching an impressive US$ 5.3 billion by 2033. This growth is fueled by the rising...